Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
about
Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterationsExploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosisIndependent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomasMolecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesotheliomaAurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage.Uncovering the molecular machinery of the human spindle--an integration of wet and dry systems biology.Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cellsOncogenic fibulin-5 promotes nasopharyngeal carcinoma cell metastasis through the FLJ10540/AKT pathway and correlates with poor prognosis.Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis.Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancerCentrosomal protein 55 (Cep55) stability is negatively regulated by p53 protein through Polo-like kinase 1 (Plk1)FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.Reduced expression of TRF1 is associated with tumor progression and poor prognosis in oral squamous cell carcinoma.FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity.Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resection.Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinomaLow expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients.Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinomaCentrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway.Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxelIdentification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors.CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma.Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.The expression of activin receptor-like kinase 1 among patients with head and neck cancer.Prognostic molecular markers in cancer - quo vadis?Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.CEP55 contributes to human gastric carcinoma by regulating cell proliferation.Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.FOXM1 coming of age: time for translation into clinical benefits?Linking expression of FOXM1, CEP55 and HELLS to tumorigenesis in oropharyngeal squamous cell carcinoma.Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis.Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.High levels of centrosomal protein 55 expression is associated with poor clinical prognosis in patients with cervical cancer.CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerCEP55 Promotes Cell Motility via JAK2⁻STAT3⁻MMPs Cascade in Hepatocellular CarcinomaSPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
P2860
Q21562666-729BBEC7-1B93-4ED7-9E74-830A3A5CC60FQ28276344-389C53FC-2102-4FC6-B408-00BC355343F9Q28277102-B8A72AEF-8BCB-4CF3-9D35-CE2353350600Q28482133-F918CE31-5249-4E00-9EA4-B733807BD5D3Q33688594-57B52216-4353-423B-AE24-3DA30DF8CB7DQ33918811-6A874674-5940-48F4-8F0B-5570CC8EF30EQ34185710-1140666A-1A32-4292-A5D4-F588AD2FFC55Q34199659-BE457428-BBE1-472A-B6B3-7997056E444CQ34284130-926D669E-9C34-4C1C-A7B9-18F1EF54E8C3Q34956879-3889336E-63C2-4EF6-9C3C-C6EE32A68F79Q35080861-8CFDDC1C-85E6-4FD4-ABCC-53C7BBC4B2B7Q35289524-7670D5C8-4FDF-4A4C-B760-0FE29E3FD16EQ35493637-4E41F45B-FD72-4AB9-A702-83F017F1BDA9Q35763224-E4888BF4-BE62-4F0E-8ADB-8C47ED8D2F8EQ36164237-684EF863-9885-46C8-BB67-0004760BA082Q36230464-E2CACC00-684F-4663-9244-37F7BEFDF2B0Q36476460-C407C78E-4691-4855-A15F-0FB612CA13DBQ36840389-F2181412-D7DA-46EC-9BDA-4A61B690DB8FQ36922664-4FA9DA5C-C7B0-4E31-B95D-022A67F56D83Q37054775-FA997C53-EA18-4725-868A-A358D7593D1CQ37129819-E0B6EF24-2047-4799-B909-DAEF46D4CD65Q37133643-9ED5E6D5-DFEC-4B33-9424-1E586B757BDAQ37153952-B329D03F-C6D2-479F-BE48-A84C4AA725C1Q37348740-8063B264-6599-4CDD-8AD7-1D893AAE0BA6Q37593928-EAE099D7-FC5A-4BF1-B6F3-C718C2AC7FB8Q37750805-F6E01F47-F2E3-4FA7-94CF-9A56E8CE583CQ38085283-6E52A55A-A361-4366-96F3-FEFAA0C274ABQ38120287-4BF9E5AF-D879-471D-83C4-C5247B17A645Q38444145-0AEC5937-1EC6-4857-8A61-AA65DA2EB944Q39037303-FB3E7633-0AF8-4A6D-90BB-F613031B1BCFQ40871740-EC255FDB-9A42-4056-9DFF-69AFE21FF90CQ41859224-527750B9-BD3C-4D45-9282-C1E88B995DEBQ44013778-D369FF8B-1622-4B6A-A8F8-95AE8E464D0AQ47654322-CB0A2C30-7DD4-49C5-8192-0D2B2E0F758FQ47967361-0895B4FF-C08B-4B09-9598-7011475A2B4EQ55014124-D32D7D41-323F-40C6-A1BE-B3B92B56F2E0Q58779939-64865F01-9CF5-4A1B-9970-CEFE81B3975FQ58795154-F792BB9D-ECC6-4BBC-B5D9-DF6FFCB3C225Q58796319-D321FDBC-FF0C-4AFC-9F47-013F67AEF10C
P2860
Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@en
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@nl
type
label
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@en
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@nl
prefLabel
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@en
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@nl
P2093
P2860
P356
P1433
P1476
Expression of FLJ10540 is corr ...... ased FOXM1 and MMP-2 activity.
@en
P2093
C-Y F Huang
H-C Chuang
P2860
P2888
P304
P356
10.1038/ONC.2009.128
P407
P577
2009-06-15T00:00:00Z